Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial

Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial

Abstract Background Adjuvanted inactivated influenza vaccine (aIIV) and high-dose inactivated influenza vaccine (HD-IIV) are U.S.-licensed for adults aged ≥ 65 years. This study compared serum hemagglutination inhibition (HAI) antibody titers for the A(H3N2) and A(H1N1)pdm09 and B strains after triv...

Full description

Bibliographic Details
Main Authors: Kenneth E. Schmader, Christine K. Liu, Brendan Flannery, Wes Rountree, Heidi Auerbach, Elizabeth D. Barnett, Elizabeth P. Schlaudecker, Christopher A. Todd, Marek Poniewierski, Mary A. Staat, Theresa Harrington, Rongxia Li, Karen R. Broder, Emmanuel B. Walter
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Immunity & Ageing
Subjects:
Influenza vaccine
Immunogenicity
Aged
Adjuvanted influenza vaccine
High dose influenza vaccine
Online Access:https://doi.org/10.1186/s12979-023-00355-7

Internet

https://doi.org/10.1186/s12979-023-00355-7

Similar Items